378 related articles for article (PubMed ID: 7729636)
1. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease.
Schreiber S; Heinig T; Thiele HG; Raedler A
Gastroenterology; 1995 May; 108(5):1434-44. PubMed ID: 7729636
[TBL] [Abstract][Full Text] [Related]
2. Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease.
Schreiber S; Heinig T; Panzer U; Reinking R; Bouchard A; Stahl PD; Raedler A
Gastroenterology; 1995 Jan; 108(1):21-33. PubMed ID: 7806044
[TBL] [Abstract][Full Text] [Related]
3. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation.
Nikolaus S; Bauditz J; Gionchetti P; Witt C; Lochs H; Schreiber S
Gut; 1998 Apr; 42(4):470-6. PubMed ID: 9616306
[TBL] [Abstract][Full Text] [Related]
4. Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10.
Kucharzik T; Lügering N; Weigelt H; Adolf M; Domschke W; Stoll R
Clin Exp Immunol; 1996 Jun; 104(3):483-90. PubMed ID: 9099934
[TBL] [Abstract][Full Text] [Related]
5. Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease.
McAlindon ME; Hawkey CJ; Mahida YR
Gut; 1998 Feb; 42(2):214-9. PubMed ID: 9536946
[TBL] [Abstract][Full Text] [Related]
6. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
Reinecker HC; Steffen M; Witthoeft T; Pflueger I; Schreiber S; MacDermott RP; Raedler A
Clin Exp Immunol; 1993 Oct; 94(1):174-81. PubMed ID: 8403503
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of immunoregulatory cytokines on peripheral blood monocytes from patients with inflammatory bowel disease.
Kucharzik T; Lügering N; Adolf M; Domschke W; Stoll R
Dig Dis Sci; 1997 Apr; 42(4):805-12. PubMed ID: 9125653
[TBL] [Abstract][Full Text] [Related]
8. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
[TBL] [Abstract][Full Text] [Related]
9. Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-infected patients.
Steffen M; Reinecker HC; Petersen J; Doehn C; Pflüger I; Voss A; Raedler A
Clin Exp Immunol; 1993 Jan; 91(1):30-6. PubMed ID: 8419083
[TBL] [Abstract][Full Text] [Related]
10. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production.
Liu Z; Geboes K; Colpaert S; D'Haens GR; Rutgeerts P; Ceuppens JL
J Immunol; 2000 Apr; 164(7):3608-15. PubMed ID: 10725717
[TBL] [Abstract][Full Text] [Related]
11. IL-10 synergizes with IL-4 and IL-13 in inhibiting lysosomal enzyme secretion by human monocytes and lamina propria mononuclear cells from patients with inflammatory bowel disease.
Lügering N; Kucharzik T; Stein H; Winde G; Lügering A; Hasilik A; Domschke W; Stoll R
Dig Dis Sci; 1998 Apr; 43(4):706-14. PubMed ID: 9558023
[TBL] [Abstract][Full Text] [Related]
12. Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation.
Autenrieth IB; Bucheler N; Bohn E; Heinze G; Horak I
Gut; 1997 Dec; 41(6):793-800. PubMed ID: 9462212
[TBL] [Abstract][Full Text] [Related]
13. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.
Bamias G; Martin C; Marini M; Hoang S; Mishina M; Ross WG; Sachedina MA; Friel CM; Mize J; Bickston SJ; Pizarro TT; Wei P; Cominelli F
J Immunol; 2003 Nov; 171(9):4868-74. PubMed ID: 14568967
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of IL-16 in inflammatory bowel disease.
Seegert D; Rosenstiel P; Pfahler H; Pfefferkorn P; Nikolaus S; Schreiber S
Gut; 2001 Mar; 48(3):326-32. PubMed ID: 11171821
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease.
Docena G; Rovedatti L; Kruidenier L; Fanning A; Leakey NA; Knowles CH; Lee K; Shanahan F; Nally K; McLean PG; Di Sabatino A; MacDonald TT
Clin Exp Immunol; 2010 Oct; 162(1):108-15. PubMed ID: 20731675
[TBL] [Abstract][Full Text] [Related]
16. In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease.
Reimund JM; Dumont S; Muller CD; Kenney JS; Kedinger M; Baumann R; Poindron P; Duclos B
Gut; 1997 Apr; 40(4):475-80. PubMed ID: 9176074
[TBL] [Abstract][Full Text] [Related]
17. Colonic mucosal interleukin 1 receptor antagonist in inflammatory bowel disease.
Nishiyama T; Mitsuyama K; Toyonaga A; Sasaki E; Tanikawa K
Digestion; 1994; 55(6):368-73. PubMed ID: 7705549
[TBL] [Abstract][Full Text] [Related]
18. Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease.
Rugtveit J; Nilsen EM; Bakka A; Carlsen H; Brandtzaeg P; Scott H
Gastroenterology; 1997 May; 112(5):1493-505. PubMed ID: 9136827
[TBL] [Abstract][Full Text] [Related]
19. IL-4 Signaling Mechanisms in Inflammatory Bowel Disease Mononuclear Phagocytes.
Rückert Y; Schindler U; Heinig T; Nikolaus S; Raedler A; Schreiber S
Inflamm Bowel Dis; 1996; 2(4):244-52. PubMed ID: 23282589
[TBL] [Abstract][Full Text] [Related]
20. Imbalance of the interleukin 1 system in colonic mucosa--association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2.
Andus T; Daig R; Vogl D; Aschenbrenner E; Lock G; Hollerbach S; Köllinger M; Schölmerich J; Gross V
Gut; 1997 Nov; 41(5):651-7. PubMed ID: 9414973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
